Qpex Biopharma, Inc.

Shionogi & Co. Ltd. and its US subsidiary Qpex Biopharma, Inc. are to open a shared R&D facility focused on infectious diseases and antimicrobial resistance (AMR) in San Diego in the spring of 2025

With understanding of immune function advancing in leaps and bounds and a continuing proliferation of tools to manipulate it, expectations are high for advances in oncology and immunology over the com

It’s only half-way through the month of July but Chinese bioventures have already raised new funds at a record-setting pace to accelerate clinical development of their new drugs and cell therapies. No

Forma Therapeutics Inc. has gone through a lot of change during the past year after its most lucrative partnership was downsized, but after adding $100m in series D venture capital to its balance she